The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant

Upfront autologous stem cell transplant (ASCT) is the standard of care for newly diagnosed multiple myeloma (MM) patients. However, relapse is ubiquitous and therapy-related myeloid neoplasms (t-MN) post-ASCT are commonly associated with poor outcomes. We hypothesized that the enrichment of abnormal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanwar, Saurabh, Jacob, Eapen K., Greiner, Carl, Pavelko, Kevin, Strausbauch, Michael, Anderson, Emilie, Arsana, Arini, Weivoda, Megan, Shah, Mithun Vinod, Kourelis, Taxiarchis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522581/
https://www.ncbi.nlm.nih.gov/pubmed/37752130
http://dx.doi.org/10.1038/s41408-023-00920-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522581/
https://www.ncbi.nlm.nih.gov/pubmed/37752130
http://dx.doi.org/10.1038/s41408-023-00920-9

Ejemplares similares